Kelyniam Global (KLYG) 0.1200 $KLYG
Kelyniam Global Inc. Revenues Grow 54% from Prior Year
GlobeNewswire - Mon Apr 07, 9:00AM CDT
Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% vs. sales of $1,206,227 in 2012. The Kelyniam product fit and quick turnaround has captured the attention of surgeons throughout the United States. The revenue increase reflects the continued rollout in many additional hospitals. The company will provide financials on their website, kelyniam.com, when they become available in final form from the Accounting Firm.
Kelyniam Global Inc. Unveils New Product
GlobeNewswire - Wed Apr 02, 6:21AM CDT
Kelyniam Global Inc. has introduced a new product to the marketplace, the "IFS" (Integrated Fixation System) product. The product is patent pending and provides faster implantation, reduced hardware, cost savings and elimination of mundane tasks during the surgical procedure.
Mthethwa Urges IPID to Speed Up Brits Probe
All Africa Global Media - Wed Jan 15, 9:34AM CST
Police Minister Nathi Mthethwa has called on the Independent Police Investigative Directorate (IPID) to speed up the investigation into the deaths in the Brits protests.
Kelyniam Global Inc. Reports Settlement of Lawsuit
GlobeNewswire - Tue Nov 05, 6:13AM CST
Kelyniam Global Inc. (OTC: KLYG) has successfully resolved the lawsuit with former employee John Mastoloni. Per terms of the settlement agreement, details are confidential. President & CEO Tennyson Anthony stated, "While we cannot disclose details, shareholders should be pleased to know that the matter was resolved for only a fraction of the amount the company had set aside."
Kelyniam Global Inc. Announces Continued Revenue Growth & Approval to Sell Overseas
GlobeNewswire - Thu May 30, 8:25AM CDT
Kelyniam Global Inc. (OTC: KLYG), a growing company that designs, manufactures, and sells custom cranial/craniofacial implants, announced today its financial results for the year ending December 31, 2012 and also for the first quarter ended March 31, 2013.
Kelyniam Custom Cranial Implants Receive Endorsement From Skull Based Neurosurgeon Dr. Ammirati of The Ohio State University Wexner Medical Center
GlobeNewswire - Tue Jan 29, 8:00AM CST
(OTC: KLYG) Kelyniam Custom Cranial Implants, designed to fill the boney void in a patient's skull, have been endorsed by Mario Ammirati, MD, Director of Skull Based Surgery, Stereotactic Radiosurgery and the Dardinger Microneurosurgical Skull Based Laboratory, Wexner Medical Center, at the Ohio State University. This is the first product Dr. Ammirati has ever endorsed.
Kelyniam Global Inc. Revenues Grow 54% from Prior Year
GlobeNewswire - Mon Apr 07, 9:00AM CDT
Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% vs. sales of $1,206,227 in 2012. The Kelyniam product fit and quick turnaround has captured the attention of surgeons throughout the United States. The revenue increase reflects the continued rollout in many additional hospitals. The company will provide financials on their website, kelyniam.com, when they become available in final form from the Accounting Firm.
Kelyniam Global Inc. Unveils New Product
GlobeNewswire - Wed Apr 02, 6:21AM CDT
Kelyniam Global Inc. has introduced a new product to the marketplace, the "IFS" (Integrated Fixation System) product. The product is patent pending and provides faster implantation, reduced hardware, cost savings and elimination of mundane tasks during the surgical procedure.
Mthethwa Urges IPID to Speed Up Brits Probe
All Africa Global Media - Wed Jan 15, 9:34AM CST
Police Minister Nathi Mthethwa has called on the Independent Police Investigative Directorate (IPID) to speed up the investigation into the deaths in the Brits protests.
Kelyniam Global Inc. Reports Settlement of Lawsuit
GlobeNewswire - Tue Nov 05, 6:13AM CST
Kelyniam Global Inc. (OTC: KLYG) has successfully resolved the lawsuit with former employee John Mastoloni. Per terms of the settlement agreement, details are confidential. President & CEO Tennyson Anthony stated, "While we cannot disclose details, shareholders should be pleased to know that the matter was resolved for only a fraction of the amount the company had set aside."
Kelyniam Global Inc. Announces Continued Revenue Growth & Approval to Sell Overseas
GlobeNewswire - Thu May 30, 8:25AM CDT
Kelyniam Global Inc. (OTC: KLYG), a growing company that designs, manufactures, and sells custom cranial/craniofacial implants, announced today its financial results for the year ending December 31, 2012 and also for the first quarter ended March 31, 2013.
Kelyniam Custom Cranial Implants Receive Endorsement From Skull Based Neurosurgeon Dr. Ammirati of The Ohio State University Wexner Medical Center
GlobeNewswire - Tue Jan 29, 8:00AM CST
(OTC: KLYG) Kelyniam Custom Cranial Implants, designed to fill the boney void in a patient's skull, have been endorsed by Mario Ammirati, MD, Director of Skull Based Surgery, Stereotactic Radiosurgery and the Dardinger Microneurosurgical Skull Based Laboratory, Wexner Medical Center, at the Ohio State University. This is the first product Dr. Ammirati has ever endorsed.
